Muutke küpsiste eelistusi

Pharmaceutical Computer Systems Validation: Volume 2 - Real Life Case Studies [Kõva köide]

Edited by
  • Formaat: Hardback, 480 pages, kõrgus x laius: 254x178 mm, 36 Tables, black and white; 1 Line drawings, color; 97 Line drawings, black and white; 1 Halftones, color; 15 Halftones, black and white; 2 Illustrations, color; 112 Illustrations, black and white
  • Sari: Drugs and the Pharmaceutical Sciences
  • Ilmumisaeg: 15-Jun-2026
  • Kirjastus: CRC Press
  • ISBN-10: 1032981105
  • ISBN-13: 9781032981109
  • Kõva köide
  • Hind: 194,62 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 259,50 €
  • Säästad 25%
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 3-4 nädalat peale raamatu väljaandmist.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 480 pages, kõrgus x laius: 254x178 mm, 36 Tables, black and white; 1 Line drawings, color; 97 Line drawings, black and white; 1 Halftones, color; 15 Halftones, black and white; 2 Illustrations, color; 112 Illustrations, black and white
  • Sari: Drugs and the Pharmaceutical Sciences
  • Ilmumisaeg: 15-Jun-2026
  • Kirjastus: CRC Press
  • ISBN-10: 1032981105
  • ISBN-13: 9781032981109
Computerised systems play a fundamental role in the development, manufacture and supply of medical treatments. This is the third and thoroughly updated edition of the best-selling book dealing with validation, compliance and software in the pharmaceutical, healthcare and medical device industries. The first volume provides a comprehensive walk-through of lifecycle and development methodologies bringing together technological advances, latest regulatory requirements, inspection findings, and compliance strategies. New chapters have been added on agile development methodologies, data integrity, artificial intelligence and machine learning. The second volume comprises an extensive set of refreshed case studies spanning laboratory, manufacturing and supply chain systems with new contributions on databases, spreadsheets, LIMS, blockchain, mobile devices, AI-enabled systems, big data and digital twins authored by various industry experts.

Key Features





Covers organizational responsibilities, project lifecycle, operational compliance, risk management, data integrity, practical trouble shooting, handling regulatory inspections, metrics and the opportunity for performance improvement. Includes 20 new and updated case studies by industry experts, demonstrating how these computer system validation principles are put into practice. Discusses industry regulations and guidance including current thinking of US FDA on computer software assurance, the latest guidance from US FDA/EU/MHRA on data integrity and newly published ISPE GAMP 5 Guide (Second Edition). Focuses on regulatory requirements covering GCPs, GLPs, GMPs and GDPs complete with observations from inspections by US FDA and other regulators Includes new material dealing with the latest advancements concerning data integrity, machine-learning and artificial intelligence, data-lakes, cloud computing services, mobile devices, and IT tools.
Foreword. Preface. List of Contributors. About The Editor.
Abbreviations.
Chapter 1: Case Study 1: Clinical Systems.
Chapter 2: Case
Study 2: Computerized Analytical Laboratory Systems.
Chapter 3: Case Study 3:
Chromatography Data Systems.
Chapter 4: Case Study 4: Laboratory Information
Management Systems.
Chapter 5: Case Study 5: Process Instrumentation.
Chapter
6: Case Study 6: Process Control Systems (Operational Technologies: OT).
Chapter 7: Case Study 7: Process Analytical Technology.
Chapter 8: Case Study
8: Manufacturing Execution Systems and Electronic Batch Records.
Chapter 9:
Case Study 9: Building Management Systems.
Chapter 10: Case Study 10:
Spreadsheets.
Chapter 11: Case Study 11: Database Applications.
Chapter 12:
Case Study 12: Electronic Document Management Systems.
Chapter 13: Case Study
13: Enterprise Resource Planning Systems.
Chapter 14: Case Study 14:
Marketing and Supply Applications.
Chapter 15: Case Study 15: IT
Infrastructure and Associated Services.
Chapter 16: Case Study 16: Big Data
Management.
Chapter 17: Case Study 17: Web-based Applications.
Chapter 18:
Case Study 18: Blockchain.
Chapter 19: Case Study 19: Mobile Devices.
Chapter
20: Case Study 20: Medical Devices and Their Automated Manufacture.
Chapter
21: Case Study 21: AI-enabled Computerized System.
Chapter 22: Case Study 22:
Blood Establishment Computer Systems. Glossary. Index
Guy Wingate, PhD, was Vice-President of Compliance at GlaxoSmithKline until his recent retirement. A well-known speaker on computer validation, Dr Wingate has over 30 years experience in the pharmaceutical industry. He has been a visiting lecturer at the University of Manchesters M.Sc. Pharmaceutical Engineering Advanced Training program and Dublin Institute of Technologys accredited M.Sc. Validation Science program. Dr Wingate is an active member of the ISPE and was chair of the GAMP Council for 10 years which is responsible for the internationally recognized suite of GAMP Guides on computer compliance. Dr Wingates extensive list of published work includes the books Validating Corporate Computer Systems and previous editions of this book Pharmaceutical Computer Systems Validation.
Ei ole sisse logitud.